SFX by Ex Libris Inc.

Title:	Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity
Source:	Science [0036-8075] Fowler, B J yr:2014

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Penning, D. "Synthesis and Biological Evaluation of the 1.5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors." Journal of medicinal chemistry 40.13 (1997): 1347-1365.
description	2.	Hillaireau, H. "Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies." Biomaterials 34.20 (2013): 4831-8.
description	3.	Hachiya, A. "HIV-1 reverse transcriptase (RT) polymorphism 172K suppresses the effect of clinically relevant drug resistance mutations to both nucleoside and non-nucleoside RT inhibitors." Journal of biological chemistry 287.35 (2012): 29988-29999.
description	4.	Mandal, D. "Cell-penetrating homochiral cyclic peptides as nuclear-targeting molecular transporters." Angewandte Chemie (International ed. in English) 50.41 (2011): 9633-9637.
description	5.	VENKATACHALAM, T. K. "Effect of change in nucleoside structure on the activation and antiviral activity of phosphoramidate derivatives." Bioorganic & medicinal chemistry 13.18 (2005): 5408-5423.
description	6.	Schinkovitz, Samuel C. "Dynamic nature of the ligustilide complex." Journal of natural products 71.9 (2008): 1604-1611.
description	7.	Qazi, S K. "Synthesis and metabolism of naphthyl substituted phosphoramidate derivatives of stavudine." Bioorganic & medicinal chemistry 14.15 (2006): 5161-5177.
description	8.	Pancino, G. "Reply to Pauls et al.: p21 is a master regulator of HIV replication in macrophages through dNTP synthesis block." Proceedings of the National Academy of Sciences of the United States of America 111.14 (2014): -6.
description	9.	Burger, D. "Pharmacological considerations on the use of antiretrovirals in pregnancy." Current opinion in infectious diseases 26.6 (2013): 575-588.
description	10.	Huo, C. "Synthesis of phosphates and phosphates-acetates hybrids of green tea polyphenol (-)-epigallocatechine-3-gallate (EGCG) and its G ring deoxy analogs as potential anticancer prodrugs." Tetrahedron letters 52.42 (2011): 5478-5483.
description	11.	Bobone, S. "The thin line between cell-penetrating and antimicrobial peptides: The case of Pep-1 and Pep-1-K." Journal of peptide science 17.5 (2011): 335-341.
description	12.	Jha, D. "CyLoP-1: A Novel Cysteine-Rich Cell-Penetrating Peptide for Cytosolic Delivery of Cargoes." Bioconjugate chemistry 22.3 (2011): 319-328.
description	13.	Piliero, Peter J J. "Pharmacokinetic properties of nucleoside/nucleotide reverse transcriptase inhibitors." Journal of acquired immune deficiency syndromes 37 Suppl 1.1 (2004).
description	14.	Liu, H. "Molecular Insights on the Cyclic Peptide Nanotube-Mediated Transportation of Antitumor Drug 5-Fluorouracil." Molecular pharmaceutics 7.6 (2010): 1985-1994.
description	15.	Oxenius, A. "Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection." Proceedings of the National Academy of Sciences of the United States of America 99.21 (2002): 13747-13752.
description	16.	Sasaki, Y.. "Cell-penetrating peptide-conjugated XIAP-inhibitory cyclic hexapeptides enter into Jurkat cells and inhibit cell proliferation." The FEBS journal 275.23 (2008): 6011-6021.
description	17.	Georgiev, Gail t. REVERSE TRANSCRIPTASE INHIBITORS IN HIV/AIDS THERAPY. Humana Press,, 2006. 527-527.
description	18.	Venkatachalam, T. K. "Stereochemical influence on lipase-mediated hydrolysis and biological activity of stampidine and other stavudine phosphoramidates." Bioorganic & medicinal chemistry 13.5 (2005): 1763-1773.
description	19.	Mathe, C. "L-Nucleoside enantiomers as antivirals drugs: A mini-review." Antiviral research 71.2 (2006): 276-281.
description	20.	Li, X. "New and efficient approach to aryl phosphoramidate derivatives of AZT/d4T as anti-HIV prodrugs." Synlett 14 (2004): 2600-2602.